Charlotte Kilpatrick, reporter at Managing IP, sat down with Corey Salsberg of Novartis, Ellen t’Hoen of Medicines Law and Policy, and David Rosenberg formerly of GSK, to discuss how COVID-19 is reshaping the IP landscape in the life sciences industries. The guests debated IP issues including access to medicine, open science, and the role patent and technology pooling can play to accelerate vaccine research.